Class 435 :: CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY

Definition

Subclasses List

• 1.1 • DIFFERENTIATED TISSUE OR ORGAN OTHER THAN BLOOD, PER SE, OR DIFFERENTIATED TISSUE OR ORGAN MAINTAINING; COMPOSITION THEREFOR
• 1.2 • Including perfusion; composition therefor
• 1.3 • Including freezing; composition therefor
• 2 • MAINTAINING BLOOD OR SPERM IN A PHYSIOLOGICALLY ACTIVE STATE OR COMPOSITIONS THEREOF OR THEREFOR OR METHODS OF IN VITRO BLOOD CELL SEPARATION OR TREATMENT
• 3 • CONDITION RESPONSIVE CONTROL PROCESS
• 4 • MEASURING OR TESTING PROCESS INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITION OR TEST STRIP THEREFORE; PROCESSES OF FORMING SUCH COMPOSITION OR TEST STRIP
• 5 • Involving virus or bacteriophage
• 6 • Involving nucleic acid
• 7.1 • Involving antigen-antibody binding, specific binding protein assay or specific ligand-receptor binding assay
• 7.2 • Involving a micro-organism or cell membrane bound antigen or cell membrane bound receptor or cell membrane bound antibody or microbial lysate
• 7.21 • Animal cell
• 7.22 • Parasite or protozoa
• 7.23 • Tumor cell or cancer cell
• 7.24 • Leukocyte (e.g., lymphocyte, granulocyte, monocyte, etc.)
• 7.25 • Erythrocyte
• 7.3 • Flagellar-antigen or pili-antigen
• 7.31 • Fungi (e.g., yeast, mold, etc.)
• 7.32 • Bacteria or actinomycetales
• 7.33 • Staphylococcus
• 7.34 • Streptococcus
• 7.35 • Salmonella
• 7.36 • Sexually transmitted disease (e.g., chlamydia, syphilis, gonorrhea, etc.)
• 7.37 • Escherichia coli
• 7.4 • To identify an enzyme or isoenzyme
• 7.5 • Involving avidin-biotin binding
• 7.6 • Involving a modified enzyme (e.g., abzyme, recombinant, chemically altered, etc.)
• 7.7 • Assay in which a label present is an apoenzyme, prosthetic group, or enzyme cofactor
• 7.71 • Assay in which a label present is an enzyme inhibitor or functions to alter enzyme activity
• 7.72 • Assay in which a label present is an enzyme substrate or substrate analogue
• 7.8 • Involving nonmembrane bound receptor binding or protein binding other than antigen-antibody binding
• 7.9 • Assay in which an enzyme present is a label
• 7.91 • Enzyme produces product which is part of another reaction system (e.g., cyclic reaction, cascade reaction, etc.)
• 7.92 • Heterogeneous or solid phase assay system (e.g., ELISA, etc.)
• 7.93 • Competitive assay
• 7.94 • Sandwich assay
• 7.95 • Indirect assay
• 8 • Involving luciferase
• 9 • Geomicrobiological testing (e.g., for petroleum, etc.)
• 10 • Involving uric acid
• 11 • Involving cholesterol
• 12 • Involving urea or urease
• 13 • Involving blood clotting factor (e.g., involving thrombin, thromboplastin, fibrinogen, etc.)
• 14 • Involving glucose or galactose
• 15 • Involving transferase
• 16 • Involving transaminase
• 17 • Involving creatine phosphokinase
• 18 • Involving hydrolase
• 19 • Involving esterase
• 20 • Involving cholinesterase
• 21 • Involving phosphatase
• 22 • Involving amylase
• 23 • Involving proteinase
• 24 • Involving peptidase
• 25 • Involving oxidoreductase
• 26 • Involving dehydrogenase
• 27 • Involving catalase
• 28 • Involving peroxidase
• 29 • Involving viable micro-organism
• 30 • Methods of sampling or inoculating or spreading a sample; methods of physically isolating an intact micro-organism
• 31 • Testing for sterility condition
• 32 • Testing for antimicrobial activity of a material
• 33 • Using multifield media
• 34 • Determining presence or kind of micro-organism; use of selective media
• 35 • Using radioactive material
• 36 • Streptococcus; staphylococcus
• 37 • Nitrate to nitrite reducing bacteria
• 38 • Enterobacteria
• 39 • Quantitative determination
• 40 • Using multifield media
• 40.5 • Involving fixed or stabilized, nonliving microorganism, cell, or tissue (e.g., processes of staining, stabilizing, dehydrating, etc.; compositions used therefore, etc.)
• 40.51 • Involving a monolayer, smear or suspension of microorganisms or cells
• 40.52 • Involving tissue sections
• 41 • MICRO-ORGANISM, TISSUE CELL CULTURE OR ENZYME USING PROCESS TO SYNTHESIZE A DESIRED CHEMICAL COMPOUND OR COMPOSITION
• 42 • Process involving micro-organisms of different genera in the same process, simultaneously
• 43 • Preparing compound having a 1-thia-4-aza-bicyclo (3.2.0) heptane ring system (e.g., penicillin, etc.)
• 44 • By desacylation of the substituent in 6-position
• 45 • By acylation of the substituent in 6-position
• 46 • In presence of phenyl acetic acid or phenyl acetamide or their derivatives
• 47 • Preparing compound having a 1-thia-5-aza-bicyclo (4.2.0) octane ring system (e.g., cephalosporin, etc.)
• 48 • Di-substituted in 7-position
• 49 • Cephalosporin C
• 50 • By acylation of the substituent in the 7-position
• 51 • By desacylation of the substituent in the 7-position
• 52 • Preparing compound containing a cyclopentanohydrophenanthrene nucleus; nor-, homo-, or D-ring lactone derivatives thereof
• 53 • Containing heterocyclic ring
• 54 • Acting on D-ring
• 55 • Acting at 17-position
• 56 • Hydroxylating at 17-position
• 57 • Hydroxylating at 16-position
• 58 • Hydroxylating
• 59 • At 11-position
• 60 • At 11 alpha position
• 61 • Dehydrogenating; dehydroxylating
• 62 • Forming an aryl ring from "A" ring
• 63 • Preparing compound containing a prostaglandin nucleus
• 64 • Preparing compound other than saccharide containing a tetracycline nucleus (e.g., naphacene, etc.)
• 65 • Preparing compound other than saccharide containing a gibberellin nucleus (i.e., gibbane)
• 66 • Preparing compound other than saccharide containing alloxazine or isoalloxazine nucleus
• 67 • Preparing compound containing a carotene nucleus (i.e., carotene)
• 68.1 • Enzymatic production of a protein or polypeptide (e.g., enzymatic hydrolysis, etc.)
• 69.1 • Recombinant DNA technique included in method of making a protein or polypeptide
• 69.2 • Enzyme inhibitors or activators
• 69.3 • Antigens
• 69.4 • Hormones and fragments thereof
• 69.5 • Lymphokines or monokines
• 69.51 • Interferons
• 69.52 • Interleukins
• 69.6 • Blood proteins
• 69.7 • Fusion proteins or polypeptides
• 69.8 • Signal sequence (e.g., beta-galactosidase, etc.)
• 69.9 • Yeast derived
• 70.1 • Using tissue cell culture to make a protein or polypeptide
• 70.2 • Fused or hybrid cells
• 70.21 • Producing monoclonal antibody
• 70.3 • Animal tissue cell culture
• 70.4 • Blood (lymphoid) cell culture
• 70.5 • Producing interferons
• 71.1 • Using a micro-organism to make a protein or polypeptide
• 71.2 • Procaryotic micro-organism
• 71.3 • Antibiotic or toxin
• 72 • Preparing compound containing saccharide radical
• 73 • Preparing S-glycoside (e.g., lincomycin, etc.)
• 74 • Preparing O-glycoside (e.g., glucosides, etc.)
• 75 • Oxygen of the saccharide radical is directly bonded to a nonsaccharide heterocyclic ring or a fused- or bridged-ring system which contains a nonsaccharide heterocyclic ring (e.g., coumermycin, novobiocin, etc.)
• 76 • The hetero ring has eight or more ring members and only oxygen as ring hetero atoms (e.g., erythromycin, spiramycin, nystatin, etc.)
• 77 • Oxygen atom of the saccharide radical is directly linked through only acyclic carbon atoms to a nonsaccharide heterocyclic ring (e.g., bleomycin, phleomycin, etc.)
• 78 • Oxygen atom of the saccharide radical is directly bonded to a condensed ring system having three or more carboxyclic rings (e.g., dauomycin, adriamycin, etc.)
• 79 • Oxygen atom of the saccharide radical is bonded to a cyclohexyl radical (e.g., kasugamycin, etc.)
• 80 • Cyclohexyl radical is substituted by two or more nitrogen atoms (e.g., destomycin, neamin, etc.)
• 81 • Cyclohexyl radical is attached directly to a nitrogen atom of two or more N-C(=N)-N radicals (e.g., streptomycin, etc.)
• 82 • Having two saccharide radicals bonded through only oxygen to adjacent ring carbons of the cyclohexyl radical (e.g., ambutyrosin, ribostamycin, etc.)
• 83 • Containing three or more saccharide radicals (e.g., liquidomycin, neomycin, lividomycin, etc.)
• 84 • Preparing nitrogen-containing saccharide
• 85 • N-glycoside
• 86 • Cobalamin (i.e., vitamin B12, LLD factor)
• 87 • Nucleoside
• 88 • Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine nucleosides, etc.)
• 89 • Nucleotide
• 90 • Dinucleotide (e.g., NAD, etc.)
• 91.1 • Polynucleotide (e.g., nucleic acid, oligonucleotide, etc.)
• 91.2 • Acellular exponential or geometric amplification (e.g., PCR, etc.)
• 91.21 • Involving the making of multiple RNA copies
• 91.3 • Polynucleotide contains only ribonucleotide monomers
• 91.31 • Involving catalytic ribonucleic acid
• 91.32 • Prepared from virus, prokaryotic acid
• 91.33 • 9 Involving virus
• 91.4 • Modification or preparation of a recombinant DNA vector
• 91.41 • By insertion or addition of one or more nucleotides
• 91.42 • Involving deletion of a nucleotide or nucleotides from a vector
• 91.5 • Acellular preparation of polynucleotide
• 91.51 • Involving RNA as a starting material or intermediate
• 91.52 • Involving a ligase (6.)
• 91.53 • Involving a hydrolase (3.)
• 92 • Having a fused ring containing a six-membered ring having two N-atoms in the same ring (e.g., purine based mononucleotides, etc.)
• 93 • Mashing or wort making
• 94 • Produced by the action of an isomerase (e.g., fructose by the action of xylose isomerase on glucose, etc.)
• 95 • Produced by the action of a beta-amylase (e.g., maltose by the action of beta-amylase on amylose, etc.)
• 96 • Produced by the action of an exo-1.4 alpha glucosidase (e.g., dextrose by the action of glucoamylase on starch, etc.)
• 97 • Produced by the action of a glycosyl transferase (e.g., alpha, beta, gamma-cyclodextrins by the action of glycosyl transferase on starch, etc.)
• 98 • Produced by the action of an alpha-1, 6-glucosidase (e.g., amylose debranched amylopectin by the action of pullulanase, etc.)
• 99 • Produced by the action of a carbohydrase (e.g., maltose by the action of alpha amylase on starch, etc.)
• 100 • Disaccharide
• 101 • Polysaccharide of more than five saccharide radicals attached to each other by glycosidic bonds
• 102 • Pullulan
• 103 • Dextran
• 104 • Xanthan; i.e., xanthomonas-type heteropolysaccharides
• 105 • Monosaccharide
• 106 • Preparing alpha or beta amino acid or substituted amino acid or salts thereof
• 107 • Proline; hydroxyproline; histidine
• 108 • Tryptophan; tyrosine; phenylalanine; 3,4 dihydroxyphenylalanine
• 109 • Aspartic acid (asparaginic acid); asparagine
• 110 • Glutamic acid; glutamine
• 111 • Utilizing biotin or its derivatives
• 112 • Utilizing surfactant fatty acids or fatty acid esters (i.e., having seven or more atoms)
• 113 • Methionine; cysteine; cystine
• 114 • Citrulline; arginine; ornithine
• 115 • Lysine; diaminopimelic acid; threonine; valine
• 116 • Alanine; leucine; isoleucine; serine; homoserine
• 117 • Preparing heterocyclic carbon compound having only O, N, S, Se, or Te as ring hetero atoms
• 118 • Containing two or more hetero rings
• 119 • Containing at least two hetero rings bridged or fused among themselves or bridged or fused with a common carbocyclic ring system, (e.g., rifamycin, etc.)
• 120 • Nitrogen or oxygen hetero atom and at least one other diverse hetero ring atom in the same ring
• 121 • Nitrogen as only ring hetero atom
• 122 • Containing six-membered hetero ring
• 123 • Oxygen as only ring hetero atom
• 124 • Containing a hetero ring of at least seven ring members (e.g., zearalenone, macrocyclic lactones, etc.)
• 125 • Containing six-membered hetero ring (e.g., fluorescein, etc.)
• 126 • Containing five-membered hetero ring (e.g., griseofulvin, etc.)
• 127 • Preparing compound containing at least three carbocyclic rings
• 128 • Preparing nitrogen-containing organic compound
• 129 • Amide (e.g., chloramphenicol, etc.)
• 130 • Preparing sulfur-containing organic compound
• 131 • Preparing organic compound containing a metal or atom other than H, N, C, O, or halogen
• 132 • Preparing oxygen-containing organic compound
• 133 • Containing quinone nucleus (i.e., quinoid structure)
• 134 • Fat; fatty oil; ester-type wax; higher fatty acid (i.e., having at least seven carbon atoms in an unbroken chain bound to a carboxyl group); oxidized oil or fat
• 135 • Carboxylic acid ester
• 136 • Containing a carboxyl group
• 137 • Sugar acid having five or more carbon atoms (i.e., aldonic, keto-aldonic, or saccharic acid)
• 138 • Alpha-ketogulonic acid (i.e., 2-ketogulonic acid)
• 139 • Lactic acid
• 140 • Acetic acid
• 141 • Propionic or butyric acid
• 142 • Polycarboxylic acid
• 143 • Having keto group (e.g., alpha-ketoglutaric acid, etc.)
• 144 • Tricarboxylic acid (e.g., citric acid, etc.)
• 145 • Dicarboxylic acid having four or less carbon atoms (e.g., fumaric, maleic, etc.)
• 146 • Hydroxy carboxylic acid
• 147 • Containing carbonyl group
• 148 • Ketone
• 149 • Cyclopentanone or cyclopentadione containing compound
• 150 • Acetone containing product
• 151 • Substrate contains grain or cereal material
• 152 • Substrate contains protein as nitrogen source
• 153 • Substrate contains inorganic nitrogen source
• 154 • Substrate contains inorganic compound, other than water
• 155 • Containing hydroxy group
• 156 • Aromatic
• 157 • Acyclic
• 158 • Polyhydric
• 159 • Glycerol
• 160 • Butanol
• 161 • Ethanol
• 162 • Multiple stages of fermentation; multiple types of micro-organisms or reuse of micro-organisms
• 163 • Produced as by-product, or from waste, or from cellulosic material substrate
• 164 • Substrate contains sulphite waste liquor or citrus waste
• 165 • Substrate contains cellulosic material
• 166 • Preparing hydrocarbon
• 167 • Only acyclic
• 168 • Preparing element or inorganic compound except carbon dioxide
• 169 • Using actinomycetales
• 170 • Using bacteria
• 171 • Using fungi
• 440 • PROCESS OF MUTATION, CELL FUSION, OR GENETIC MODIFICATION
• 441 • Mutation employing a chemical mutagenic agent
• 442 • By replacement of standard nucleic acid base with base analog (e.g., 5-bromouracil, etc.)
• 443 • By use of intercalating agent (e.g., acridine orange, etc.)
• 444 • By use of alkylating agent (e.g., nitrosoguanidine, etc.)
• 445 • By use of oxidative deamination agent (e.g., nitrous acid, etc.)
• 446 • Mutation employing radiation or electricity
• 447 • X-ray irradiation
• 448 • Ultraviolet irradiation
• 449 • Fusion of cells
• 450 • Employing electric current
• 451 • One of the fusing cells is a human antibody-producing cell
• 452 • One of the fusing cells is a mouse antibody-producing cell
• 453 • One of the fusing cells is a plant cell
• 454 • One of the fusing cells is a microorganism (e.g., prokaryote, fungus, etc.)
• 455 • Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within an animal cell
• 456 • The polynucleotide is encapsidated within a virus or viral coat
• 457 • Helper virus is present
• 458 • The polynucleotide is coated with or encapsulated within a lipid containing material (e.g., liposome, etc.)
• 459 • Involving particle-mediated transfection (i.e., biolistic transfection)
• 460 • Involving laser treatment of the cell before or during transfection
• 461 • Involving electroporation
• 462 • Involving site-specific recombination (e.g., Cre-lox, etc.)
• 463 • Involving general or homologous recombination (e.g., gene targeting, etc.)
• 464 • Involving gene duplication within the cell (e.g., amplification, co-amplification, etc.)
• 465 • Involving co-transfection
• 466 • The polynucleotide is a shuttle vector or a transiently replicating hybrid vector
• 467 • Introducing an oncogene to establish a cell line
• 468 • Introduction of a polynucleotide molecule into or rearrangement of a nucleic acid within a plant cell
• 469 • Introduction via Agrobacterium
• 470 • Introduction via electroporation, particle, fiber or microprojectile mediated insertion, or injection
• 471 • Introduction of a polynucleotide molecule into or rearrangement of nucleic acid within a microorganism (e.g., bacteria, protozoa, bacteriophage, etc.)
• 472 • The polynucleotide is encapsidated within a bacteriophage, bacteriophage coat, or transducing particle
• 473 • The polynucleotide contains a transposon
• 474 • The polynucleotide is a cosmid
• 475 • The polynucleotide is unencapsidated bacteriophage or viral nucleic acid
• 476 • The polynucleotide is a plasmid or episome
• 477 • Plasmid or episome contains DNA targeting homologous recombination to bacteriophage, viral, or chromosomal DNA within a microorganism
• 478 • Plasmid or episome contains at least part of a gene encoding a restriction endonuclease or modification enzyme
• 479 • Plasmid or episome confers the ability to utilize directly a compound which a wild type microorganism is unable to utilize
• 480 • Plasmid or episome contains at least part of a gene encoding a toxin or encoding for virulence or pathogenicity
• 481 • Plasmid or episome contains a gene which complements a nutritional deficiency mutation
• 482 • Plasmid or episome contains a gene which confers resistance to metal, silicon, selenium, or tellurium toxicity
• 483 • Yeast is a host for the plasmid or episome
• 484 • Mycelial fungus is a host for the plasmid or episome
• 485 • Microorganism of the genus Bacillus is a host for the plasmid or episome
• 486 • Microorganism of the genus Streptomyces is a host for the plasmid or episome
• 487 • Microorganism of the genus Brevibacterium or the genus Corynebacterium is a host for the plasmid or episome
• 488 • Microorganism of the genus Escherichia is a host for the plasmid or episome
• 489 • Plural nonidentical plasmids are introduced into a host microorganism or culture thereof (e.g., plasmid is part of a library, etc.)
• 490 • The polynucleotide is an unbranched linear fragment
• 173.1 • TREATMENT OF MICRO-ORGANISMS OR ENZYMES WITH ELECTRICAL OR WAVE ENERGY (E.G., MAGNETISM, SONIC WAVES, ETC.)
• 173.2 • Enzyme treated
• 173.3 • Modification of viruses (e.g., attenuation, etc.)
• 173.4 • Cell membrane or cell surface is target
• 173.5 • Membrane permeability increased
• 173.6 • Electroporation
• 173.7 • Lytic effect produced (e.g., disruption of cell membrane for release of subcellular parts; e.g., nucleic acids, etc.)
• 173.8 • Metabolism of micro-organism enhanced (e.g., growth enhancement or increased production of microbial product)
• 173.9 • Concentration, separation, or purification of micro-organisms
• 174 • CARRIER-BOUND OR IMMOBILIZED ENZYME OR MICROBIAL CELL; CARRIER-BOUND OR IMMOBILIZED CELL; PREPARATION THEREOF
• 175 • Multi-enzyme system
• 176 • Enzyme or microbial cell is immobilized on or in an inorganic carrier
• 177 • Enzyme or microbial cell is immobilized on or in an organic carrier
• 178 • Carrier is carbohydrate
• 179 • Carbohydrate is cellulose or derivative thereof
• 180 • Carrier is synthetic polymer
• 181 • Attached to the carrier via a bridging agent
• 182 • Enzyme or microbial cell is entrapped within the carrier (e.g., gel, hollow fibre)
• 183 • ENZYME (E.G., LIGASES (6. ), ETC.), PROENZYME; COMPOSITIONS THEREOF; PROCESS FOR PREPARING, ACTIVATING, INHIBITING, SEPARATING, OR PURIFYING ENZYMES
• 184 • Enzyme inactivation by chemical treatment
• 185 • Malt
• 186 • Pancreatin
• 187 • Preparing granular- or free-flowing enzyme composition
• 188 • Stablizing an enzyme by forming a mixture, an adduct or a composition, or formation of an adduct or enzyme conjugate
• 188.5 • Catalytic antibody
• 189 • Oxidoreductase (1) (e.g., luciferase)
• 190 • Acting on CHOH group as donor (e.g., glucose oxidase, lactate dehydrogenase (1.1))
• 191 • Acting on nitrogen-containing compound as donor (1.2, 1.5, 1.7)
• 192 • Acting on hydrogen peroxide as acceptor (1.11)
• 193 • Transferase other than ribonuclease (2.)
• 194 • Transferring phosphorus containing group (e.g., kineases, etc.(2.7))
• 195 • Hydrolase (3)
• 196 • Acting on ester bond (3.1)
• 197 • Carboxylic ester hydrolase (3.1.1)
• 198 • Triglyceride splitting (e.g., lipase, etc. (3.1.1.3))
• 199 • Ribonuclease (3.1.4)
• 200 • Acting on glycosyl compound (3.2)
• 201 • Acting on alpha-1, 4-glucosidic bond, (e.g., hyaluronidase, invertase, amylase, etc. (some 3.2.1))
• 202 • Alpha-amylase, microbial source
• 203 • Fungal source
• 204 • Alpha-amylase, plant source (3.2.1.1)
• 205 • Glucoamylase (3.2.1.3)
• 206 • Acting on beta-1, 4 link between N-acetylmuramic acid and 2-acetylamino 2 deoxy-D-glucose (e.g., lysozyme, etc.)
• 207 • Acting on beta-galatose-glycoside bond (e.g., beta-galactosidase, etc.)
• 208 • Acting on alpha-galatose-glycoside bond (e.g., alpha-galactosidase, etc.)
• 209 • Acting on beta-1, 4-glucosidic bond (e.g., cellulase, etc. (3.2.1.4))
• 210 • Acting on alpha-1, 6-glucosidic bond (e.g., isoamylase, pullulanase, etc.)
• 211 • Dextranase (3.2.1.11)
• 212 • Acting on peptide bond (e.g., thromboplastin, leucine amino-peptidase, etc., (3.4))
• 213 • Trypsin; chymotrypsin
• 214 • Thrombin
• 215 • Urokinase
• 216 • Streptokinase
• 217 • Plasmin (i.e., fibrinolysin)
• 218 • Elastase
• 219 • Proteinase
• 220 • Derived from bacteria
• 221 • Bacteria is bacillus
• 222 • Bacillus subtilus or bacillus lichenoformis
• 223 • Derived from fungi
• 224 • From yeast
• 225 • From aspergillus
• 226 • Derived from animal tissue (e.g., rennin, etc.)
• 227 • Acting on carbon to nitrogen bond other than peptide bond (3.5)
• 228 • Acting on a linear amide linkage in linear amide
• 229 • Asparaginase
• 230 • Penicillin amidase
• 231 • Acting on amide linkage in cyclic amides (e.g., penicillinase, etc.) (3.5.2)
• 232 • Lyase (4)
• 233 • Isomerase (5)
• 234 • Glucose isomerase
• 235.1 • VIRUS OR BACTERIOPHAGE, EXCEPT FOR VIRAL VECTOR OR BACTERIOPHAGE VECTOR; COMPOSITION THEREOF; PREPARATION OR PURIFICATION THEREOF; PRODUCTION OF VIRAL SUBUNITS; MEDIA FOR PROPAGATING
• 236 • Inactivation or attenuation; producing viral subunits
• 237 • By serial passage of virus
• 238 • By chemical treatment
• 239 • Recovery or purification
• 325 • ANIMAL CELL, PER SE (E.G., CELL LINES, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING OR PRESERVING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF ISOLATING OR SEPARATING AN ANIMAL CELL OR COMPOSITION THEREOF; PROCESS OF PREPARING A COMPOSITION CONTAINING AN ANIMAL CELL; CULTURE MEDIA THEREFORE
• 326 • Animal cell, per se, expressing immunoglobulin, antibody, or fragment thereof
• 327 • Immunoglobulin or antibody is anti-idiotypic
• 328 • Immunoglobulin or antibody is chimeric, mutated, or a recombined hybrid (e.g., bifunctional, bispecific, rodent-human chimeric, single chain, rFv, immunoglobuin fusion protein, etc.)
• 329 • Immunoglobulin or antibody binds an oligosaccharide structure other than nucleic acid
• 330 • Immunoglobulin or antibody binds an expression product of a cancer related gene or fragment thereof (e.g., oncogene, proto-oncogene, etc.)
• 331 • Immunoglobulin or antibody binds a specifically identified amino acid sequence
• 332 • Immunoglobulin or antibody binds a microorganism or normal or mutant component or product thereof (e.g., animal cell, cell surface antigen, secretory product, etc.)
• 333 • Binds a nucleic acid or derivative or component thereof (e.g., DNA, RNA, DNA-RNA, hybrid, nucleotide, nucleoside, carcinogen-DNA adduct, etc.)
• 334 • Binds a receptor (e.g., transferrin receptor, Fc receptor, dihydropyridine receptor, IL-2 receptor, etc.)
• 335 • Binds a lymphokine, cytokine, or other secreted growth regulatory factor, differentiation factor, intercellular mediator specific for a hematopoietic cell (e.g., interleukin, interferon, erythropoietin, etc.)
• 336 • Binds a hormone or other secreted growth regulatory factor, differentiation factor, intercellular mediator, or neurotransmitter (e.g., insulin, human chorionic gonadotropin, intragonadal regulatory protein, Mullerian inhibiting substance, inhibin, epidermal growth factor, nerve growth factor, dopamine, norepinephrine, etc.)
• 337 • Binds a plasma protein, serum protein, or fibrin (e.g., clotting factor fibrinolytic factor, complement factor, immunoglobulin, apolipoprotein, etc.)
• 338 • Binds an enzyme
• 339 • Binds a virus or component or product thereof (e.g., virus associated antigen, etc.)
• 339.1 • Binds a retrovirus or component or product thereof (e.g., HIV, LAV, HTLV, etc.)
• 340 • Binds a bacterium or similar microorganism or component or product thereof (e.g., Streptococcus, Legionella, Mycoplasma, bacterium associated antigen, exotoxin, etc.)
• 341 • Binds a fungus or plant cell or component or product thereof (e.g., fungus associated antigen, etc.)
• 342 • Binds a parasitic protozoan or metazoan cell or component or product thereof; (e.g., Dirofilaria, Eimeria, Coccidia, Trichinella, parasite cell surface antigen, etc.)
• 343 • Binds a hematopoietic cell or component or product thereof (e.g., erythrocyte, granulocyte, macrophage, monocyte, platelet, myelogenous leukemia cell, bone marrow stem cell, granulocytic cell surface antigen, hemoglobin, thrombospondin, glycophorin, etc.)
• 343.1 • Binds a lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage, acute lymphoblastic leukemia cell, B-lymphocytic cell surface antigen, etc.)
• 343.2 • Binds a T-lymphocytic cell or component or product thereof (e.g., T-cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell surface antigen, etc.)
• 344 • Binds a cancer cell or component or product thereof (e.g., cell surface antigen, etc.)
• 344.1 • Binds an antigen characterized by name or molecular weight (e.g., CEA, NCA, CC glycoprotein, melanoma gp 150 antigen, etc.)
• 345 • Immunoglobulin or antibody binds a drug, hapten, hapten-carrier complex, or specifically identified chemical structure (e.g., theophylline, digoxin, etc.)
• 346 • Fused or hybrid cell, per se
• 347 • Two or more cell types, per se, in co-culture
• 348 • Insect cell, per se
• 349 • Avian cell, per se
• 350 • Canine cell, per se
• 351 • Feline cell, per se
• 352 • Rodent cell, per se
• 353 • Rat (i.e., Rattus)
• 354 • Mouse (i.e., Mus)
• 355 • Blood or lymphatic origin or derivative
• 356 • L cell or derivative (e.g., Ltk(-), etc.)
• 357 • Fibroblast, fibroblast-like cell or derivative (e.g., NIH 3T3, etc.)
• 358 • Chinese hamster ovary (i.e., CHO)
• 359 • Expressing recombinant tPA
• 360 • Expressing recombinant hormone or growth factor
• 361 • Expressing recombinant receptor
• 362 • Expressing recombinant antigen
• 363 • Primate cell, per se
• 364 • Monkey kidney
• 365 • COS (e.g., COS-7, etc.)
• 365.1 • Expressing recombinant lymphokine, interferon, hormone, growth factor or morphogen
• 366 • Human
• 367 • HeLa cell or derivative
• 368 • Nervous system origin or derivative
• 369 • Renal origin or derivative
• 370 • Hepatic origin or derivative
• 371 • Epithelial origin or derivative
• 372 • Blood, lymphatic, or bone marrow origin or derivative
• 372.1 • Myeloma origin or derivative
• 372.2 • B-cell or derivative
• 372.3 • T-cell or derivative
• 373 • Method of co-culturing cells
• 374 • Method of storing cells in a viable state
• 375 • Method of regulating cell metabolism or physiology
• 376 • Method of synchronizing cell division
• 377 • Method of altering the differentiation state of the cell
• 378 • Method of detaching cells, digesting tissue or establishing a primary culture
• 379 • Using mechanical means (e.g., trituration, etc.)
• 380 • Releasing bound or adhered cell using protease
• 381 • Digesting tissue with protease
• 382 • Method of culturing encapsulated cells
• 383 • Method of culturing cells in suspension
• 384 • Culture medium contains a growth factor or growth regulator
• 385 • Medium contains a colony stimulating factor
• 386 • Medium contains an interleukin
• 387 • Medium contains a polypeptide hormone
• 388 • Culture medium contains an albumin
• 389 • Culture medium contains a transferrin
• 390 • Culture medium contains an incompletely defined plant or microbial extract excluding animal extract
• 391 • Culture medium contains an animal extract
• 392 • Serum
• 393 • Using airlift or laminar flow aeration or foam culture
• 394 • Wherein culture vessel is rotated or oscillated or culture is agitated
• 395 • Solid support and method of culturing cells on said solid support
• 396 • Support is a resin
• 397 • Support is a gel surface
• 398 • Support is a fiber
• 399 • Fabric, mat, gauze, or fibrous coating
• 400 • Hollow
• 401 • Support is a membrane
• 402 • Support is a coated or treated surface
• 403 • Support is a suspendable particle
• 404 • Culture medium, per se
• 405 • Contains a growth factor or growth regulator
• 406 • Contains a polypeptide hormone
• 407 • Contains an albumin
• 408 • Contains an animal extract
• 410 • PLANT CELL OR CELL LINE, PER SE (E.G., TRANSGENIC, MUTANT, ETC.); COMPOSITION THEREOF; PROCESS OF PROPAGATING, MAINTAINING, OR PRESERVING PLANT CELL OR CELL LINE; PROCESS OF ISOLATING OR SEPARATING A PLANT CELL OR CELL LINE; PROCESS OF REGENERATING PLANT CELLS INTO TISSUE, PLANT PART, OR PLANT, PER SE, WHERE NO GENOTYPIC CHANGE OCCURS; MEDIUM THEREFORE
• 411 • Tomato cell or cell line, per se
• 412 • Corn cell or cell line, per se
• 413 • Herbicide resistant
• 414 • Tobacco cell or cell line, per se
• 415 • Soybean cell or cell line, per se
• 416 • Sunflower cell or cell line, per se
• 417 • Potato cell or cell line, per se
• 418 • Plant cell or cell line, per se, is pest or herbicide resistant or pest lethal
• 419 • Plant cell or cell line, per se, contains exogenous or foreign nucleic acid
• 420 • Culture, maintenance, or preservation techniques, per se
• 421 • Involving protoplast
• 422 • Involving conifer cell or tissue (e.g., pine, spruce, fir, cedar, etc.)
• 423 • Involving tomato cell or tissue
• 424 • Involving corn cell or tissue
• 425 • Involving tobacco cell or tissue
• 426 • Involving soybean cell or tissue
• 427 • Involving cotton cell or tissue
• 428 • Involving sunflower cell or tissue
• 429 • Involving potato cell or tissue
• 430 • Involving regeneration or propagation into a plant or plant part
• 430.1 • Involving callus or embryonic stage
• 431 • Medium, per se, for culture, maintenance, regeneration, etc.
• 242 • SPORE FORMING OR ISOLATING PROCESS
• 243 • MICRO-ORGANISM, PER SE (E.G., PROTOZOA, ETC.); COMPOSITIONS THEREOF; PROCES OF PROPAGATING, MAINTAINING OR PRESERVING MICRO-ORGANISMS OR COMPOSITIONS THEREOF; PROCESS OF PREPARING OR ISOLATING A COMPOSITION CONTAINING A MICRO-ORGANISM; CULTURE MEDIA THEREFOR
• 244 • Chemical stimulation of growth or activity by addition of chemical compound which is not an essential growth factor; stimulation of growth by removal of a chemical compound
• 245 • Adaptation or attenuation of cells
• 246 • Foam culture
• 247 • Utilizing media containing lower alkanol (i.e., having one to six carbon atoms)
• 248 • Utilizing media containing hydrocarbon
• 249 • Aliphatic
• 250 • Having five or less carbon atoms
• 251 • Utilizing media containing waste sulphite liquor
• 252 • Utilizing media containing cellulose or hydrolysates thereof
• 252.1 • Bacteria or actinomycetales; media therefor
• 252.2 • Rhizobium or agrobacterium
• 252.3 • Transformants (e.g., recombinant DNA or vector or foreign or exogenous gene containing, fused bacteria, etc.)
• 252.31 • Bacillus (e.g., B. subtilis, B. thuringiensis, etc.)
• 252.32 • Brevibacterium or corynebacterium
• 252.33 • Escherichia (e.g., E. coli, etc.)
• 252.34 • Pseudomonas
• 252.35 • Streptomyces
• 252.4 • Mixed culture
• 252.5 • Bacillus (e.g., B. subtilis, B. thuringiensis, etc.)
• 252.6 • Actinoplanes
• 252.7 • Clostridium
• 252.8 • Escherichia (e.g., E. coli, etc.) or salmonella
• 252.9 • Lactobacillus, pediococcus, or leuconostoc
• 253.1 • Mycobacterium
• 253.2 • Nocardia
• 253.3 • Pseudomonas
• 253.4 • Streptococcus
• 253.5 • Streptomyces
• 253.6 • Culture media, per se
• 254.1 • Fungi
• 254.11 • Transformants
• 254.2 • Yeast; media therefor
• 254.21 • Saccharomyces
• 254.22 • Candida
• 254.23 • Pichia
• 254.3 • Aspergillus